Erlanger Launches GI Trial To Increase Early Colon Cancer Detection

  • Monday, February 8, 2021
Erlanger Health System announces the beginning of a clinical trial looking at the use of artificial intelligence technology for improving polyp detection during colonoscopy with the ME-APDSTM device by Magentiq Eye LTD.   
 
The trial utilizes artificial intelligence software during a routine screening colonoscopy to identify abnormalities called polyps in the lining of the colon. The researchers aim to increase polyp detection rates in patients with the AI acting as an extra set of eyes for the endoscopist.
The device’s software reads the video screen at the same time as the doctor performing the colonoscopy. 
 
“With this system, we target to have more accurate colonoscopy tests and more polyps detected,” said Dr. Dror Zur, CEO of Magentiq Eye. 
 
The AI software was taught how to detect abnormalities after being fed thousands of images showing these issues in various stages and forms. 
 
“We think cancers that happen between colonoscopies are due to missed polyps hiding behind the folds or flat and difficult to find polyps,” said Dr. Arslan Kahloon, chief of gastroenterology at Erlanger Health System and principal physician for the Erlanger research team in this trial. “So if we can find these polyps with any kind of extra detection system then we can deal with them accordingly.”
 
There is no additional risk or cost to patients compared to regular colonoscopy with an increased amount of polyps removed. 
 
The study is officially open and recruiting participants. For more information or to make an appointment visit, Erlanger.org or call 778-4830. The study is in collaboration with the University of Tennessee Medical School and CTN2 Clinical Trials of Tennessee.
Living Well
Local Non-Profit To Open 1st Ever Community Garden In Soddy-Daisy
  • 4/9/2024

Winning a grant from the KFC Foundation called the Kentucky Fried Wishes Grant, KELCURT Foundation worked with Soddy-Daisy City officials to find land that would serve as the city’s very first ... more

Erlanger Cleft And Craniofacial Center Recognized As The Region’s Only ACPA Approved Team
  • 4/9/2024

The Erlanger Cleft and Craniofacial Center has been recognized again for being an American Cleft Palate-Craniofacial Association (ACPA) Approved Team, receiving the Cleft Palate Certification ... more

ReVIDA Recovery Centers Chattanooga Celebrates Grand Opening
  • 4/9/2024

ReVIDA Recovery Centers will celebrate its Grand Opening on Wednesday from 11 a.m.-noon at 5870 TN-153 #122 in Hixson, with an event featuring brief remarks, a ribbon cutting and tours of the ... more